BioTime Inc (NYSE American:BTX)

2.25
Delayed Data
As of 6:30pm ET
 -0.05 / -2.17%
Today’s Change
2.08
Today|||52-Week Range
3.50
+4.65%
Year-to-Date
No recent news for BioTime Inc.

Today’s Trading

Previous close2.30
Today’s open2.27
Day’s range2.24 - 2.32
Volume193,294
Average volume (3 months)446,069
Market cap$277.9M
Data as of 6:30pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)-150.00%
Earnings growth (this year)-251.47%
Earnings growth (next 5 years)--
Revenue growth (last year)-41.62%
P/E ratioNM
Price/Sales71.18
Price/Book1.71

Competitors

 Today’s
change
Today’s
% change
GERNGeron Corp+0.61+14.99%
EDGEEdge Therapeutics In...-0.02-2.11%
AGENAgenus Inc0.000.00%
BLCMBellicum Pharmaceuti...+0.07+0.89%
Data as of 4:00pm ET, 05/23/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$3.5M
Annual profit (last year)-$20.0M
Net profit margin-577.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Co-Chief Executive Officer &
Director
Michael D. West
President, Co-Chief Executive Officer &
Director
Adi Mohanty
Corporate headquarters
Alameda, California

Forecasts